Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews

ConclusionsUptake of tamoxifen is low in clinical practice. There were no socio-demographic differences in uptake, suggesting that the introduction of breast cancer preventive therapy is unlikely to create socioeconomic inequalities in cancer incidence. Women ’s decision-making was influenced by familial priorities, particularly having children.

http://link.springer.com/10.1007/s10549-018-4775-1

Source: Breast Cancer Research and Treatment - June 28, 2018 Category: Cancer & Oncology Source Type: research